W.R. Berkley (NYSE:WRB – Get Free Report) had its price objective dropped by equities researchers at Wells Fargo & Company from $66.00 to $64.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the insurance provider’s stock. Wells Fargo & Company‘s target price indicates a potential downside of 6.56% from the stock’s current price.
WRB has been the topic of several other research reports. Cantor Fitzgerald lowered W.R. Berkley from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $75.00 to $71.00 in a research note on Thursday, April 9th. UBS Group decreased their price target on W.R. Berkley from $71.00 to $69.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. Evercore reissued an “underperform” rating on shares of W.R. Berkley in a research note on Monday, March 9th. The Goldman Sachs Group reissued a “neutral” rating and set a $73.00 price target on shares of W.R. Berkley in a research note on Wednesday, January 7th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of W.R. Berkley in a research note on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $68.88.
View Our Latest Report on W.R. Berkley
W.R. Berkley Stock Performance
W.R. Berkley (NYSE:WRB – Get Free Report) last released its earnings results on Tuesday, April 21st. The insurance provider reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.17. W.R. Berkley had a return on equity of 18.99% and a net margin of 12.64%.The company had revenue of $3.69 billion for the quarter, compared to analysts’ expectations of $3.18 billion. During the same quarter in the previous year, the firm posted $1.01 EPS. The firm’s quarterly revenue was up 1.3% on a year-over-year basis. Research analysts expect that W.R. Berkley will post 4.55 EPS for the current year.
Insider Transactions at W.R. Berkley
In related news, major shareholder Sumitomo Insurance Co L. Mitsui bought 112,176 shares of W.R. Berkley stock in a transaction that occurred on Tuesday, March 3rd. The shares were purchased at an average price of $72.20 per share, with a total value of $8,099,107.20. Following the purchase, the insider owned 58,780,450 shares in the company, valued at $4,243,948,490. This represents a 0.19% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Over the last 90 days, insiders purchased 4,150,946 shares of company stock valued at $289,060,858. 23.30% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On W.R. Berkley
A number of institutional investors and hedge funds have recently bought and sold shares of WRB. Mitsui Sumitomo Insurance Co. Ltd. purchased a new stake in W.R. Berkley in the 4th quarter valued at approximately $3,542,919,000. Jefferies Financial Group Inc. purchased a new stake in W.R. Berkley in the 3rd quarter valued at approximately $682,816,000. Norges Bank purchased a new stake in W.R. Berkley in the 4th quarter valued at approximately $435,752,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in W.R. Berkley by 35,572.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,219,902 shares of the insurance provider’s stock valued at $155,660,000 after buying an additional 2,213,679 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in W.R. Berkley by 33.4% in the 3rd quarter. Invesco Ltd. now owns 4,892,799 shares of the insurance provider’s stock valued at $374,886,000 after buying an additional 1,224,363 shares in the last quarter. Hedge funds and other institutional investors own 68.82% of the company’s stock.
More W.R. Berkley News
Here are the key news stories impacting W.R. Berkley this week:
- Positive Sentiment: Q1 beat and strategic shift — WRB posted an EPS beat and management signaled a shift toward growth over rate, with quarterly ROE at ~21.2%, a key profitability metric that supports higher returns and investor confidence. W. R. Berkley signals shift toward growth vs. rate as Q1 2026 ROE reaches 21.2%
- Positive Sentiment: Record income and strong call highlights — Management reiterated capital-return priorities and Q1 produced record net income, items that support shareholder returns and valuation. W. R. Berkley Tops Q1 With Record Income
- Positive Sentiment: Value case highlighted — Analysts at Zacks point to WRB’s attractive valuation metrics and style scores, which may draw value-focused investors after the report. Here’s Why W.R. Berkley (WRB) is a Strong Value Stock
- Neutral Sentiment: Mixed operating details — While investment income and underwriting results helped EPS, premiums/revenue were slightly below some estimates, making the quarter mixed beneath the headline beat. W.R. Berkley’s Q1 Earnings Surpass Estimates, Revenues Miss
- Neutral Sentiment: Market dynamics noted — Coverage pieces highlight rising competition as the underwriting cycle shifts, which could pressure pricing going forward even as management focuses on returns. WRB Q1 deep dive: Competition rises as cycle shifts, capital returns remain a focus
- Neutral Sentiment: Full call/transcript available — Analysts and investors are parsing the transcript for reserve development, pricing comments and reinsurance/program details that will drive forward expectations. W. R. Berkley Corporation (WRB) Q1 2026 Earnings Call Transcript
- Negative Sentiment: Analyst price-target cuts/downgrade tone — Wells Fargo lowered its target to $64 (equal-weight), and other firms adjusted targets (Barclays lifted its target slightly but kept an underweight stance; Truist trimmed its target while keeping a buy). These moves can cap near-term upside and contributed to mixed market reaction. Analyst price target and rating notes (Benzinga)
About W.R. Berkley
W. R. Berkley Corporation (NYSE: WRB) is a publicly traded insurance holding company that underwrites and sells commercial property and casualty insurance, specialty insurance products, and reinsurance. Headquartered in Greenwich, Connecticut, the company operates a portfolio of underwriting businesses that focus on niche and specialty commercial risks, offering coverage tailored to industries such as transportation, construction, professional services and other commercial lines.
The company’s product mix includes primary and excess casualty, property, professional liability, environmental and other specialty lines, together with treaty and facultative reinsurance solutions.
Read More
Receive News & Ratings for W.R. Berkley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for W.R. Berkley and related companies with MarketBeat.com's FREE daily email newsletter.
